Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Variant Lung Cancer—Long-Term Results of a Randomized Clinical Trial
Vanita Noronha, Vijay Patil, Nandini Menon, Minit Shah, Anuradha Chougule, Zoya Peelay, Kumar Prabhash
Abstract
This randomized clinical trial examines whether adding chemotherapy with pemetrexed and carboplatin to gefitinib improves survival among patients with epidermal growth factor receptor ( EGFR )–variant non–small cell lung cancer.
Topics & Concepts
GefitinibPemetrexedMedicineCarboplatinLung cancerOncologyInternal medicineEpidermal growth factor receptorChemotherapyRandomized controlled trialClinical trialCancerCisplatinLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentGastric Cancer Management and Outcomes